期刊文献+

温和高温下胰腺癌细胞株PANC1对吉西他滨耐药性的影响

Mild hyperthermia affects chemoresistance of gemcitabine in pancreatic cancer PANC1 cell line
原文传递
导出
摘要 目的观察温和高温下胰腺癌细胞株PANC1对吉西他滨敏感性的影响。方法应用1μmol/L吉西他滨处理胰腺癌PANC1细胞1h后,分别置37、42、45℃水浴锅孵育1h,再继续培养0、24、48h。采用CCK.8法检测细胞增殖,AV/PI染色后上流式细胞仪检测细胞凋亡率。结果42℃及45℃孵育细胞24、48h后的细胞增殖均较37℃孵育的细胞显著降低(0.96±0.05、0.88±0.03比1.05±0.02:1.28±0.04、0.94±0.04比1.49±0.09;t值分别为4.367、25.120、3.510、12.101,P值均〈0.05),且45℃孵育的细胞增殖显著低于42℃孵育的细胞(£值分别为3.348、11.732,P值均〈0.05)。37、42、45℃孵育的吉西他滨处理的PANC1细胞48h后的细胞凋亡率分别为(7.125±0.064)%、(9.985±0.615)%、(14.845±1.987)%,3组间的差异均具有统计学意义(t值分别为10.320、9.832、4.575,P值均〈0.05)。结论温和高温可以增加PANC1细胞对吉西他滨的敏感性。 Objective To investigate the effect of mild hyperthermia on chemoresistance of gemcitabine in the pancreatic cancer cell line PANC1. Methods The PANC1 cell was treated with gemcitabine (1 μmol/L) for 1 h, then was heated at 37℃, 42℃ and 45℃ for 1 hour, and was cultured for 0 h, 24 h, 48 h. Cell growth was analyzed by CCK-8 assay. Cell apoptosis was analyzed by Annexin V- fluorescein isothiocyanate ( FITC)/propidium iodide (PI) staining. Results The proliferation of cells at 42℃ and 45℃ for 24 h and 48 h were significantly lower than that at 37℃ (0.96 ± 0.05,0.88 ± 0.03vs 1.05 ± 0.02;1.28 ±0.04,0.94 ±O. 04vs 1.49 ±0.09;t =4.367, 25. 120, P 〈0.05). The proliferation of cells at 45℃ was significantly lower than that at 42℃ ( t = 3. 348, 11. 732, P 〈 0.05 ). The cell apoptosis rates at 37℃, 42℃, 45℃ after 48 h were (7. 125 ± 0. 064) %, (9. 985 ± 0. 615 ) %, ( 14. 845 ± 1. 987 ) %, the difference among the 3 groups was statistically significant ( t = 10.320, 9. 832, 4.575, P 〈0.05 ). Conclusions Mild hyperthermia can reduce chemoresistance of gencitabine in pancreatic cancer cell PANC1.
出处 《中华胰腺病杂志》 CAS 2012年第3期189-191,共3页 Chinese Journal of Pancreatology
基金 上海卫生局科研基金
关键词 胰腺肿瘤 温和高温 吉西他滨 药物疗法 Pancreatic neoplasms Mild hyperthermia Gemeitabine Drug therapy
  • 相关文献

参考文献9

  • 1Jemal A,Siegel R,Ward E. Cancer statistics,2008[J].CA:A Cancer Journal for Clinicians,2008.71-96.doi:10.3322/CA.2007.0010.
  • 2Fiegl M,Schdemmer M,Wendtner CM. Ifosfamide,carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pretreated advanced soft tissue sarcoma of adults[J].International Journal of Hyperthermia,2004.661-670.
  • 3Westermann AM,Wiedemann GJ,Jager E. A Systemic Hyperthermia Oncologic Working Group trial.Ifosfamide,carboplatin,and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma[J].Oncology(Basel),2003.312-321.
  • 4Maluta S,Schaffer M,Pioli F. Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer:an open-label comparative cohort trial[J].Strahlentherapie Und Onkologie,2011.619-625.
  • 5Fiegl M,Schlemmer M,Wendtner CM. Ifosfamide,carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pretreated advanced soft tissue sarcoma of adults[J].International Journal of Hyperthermia,2004.661-670.
  • 6Westermann AM,Wiedemann GJ,Jager E. A Systemic Hyperthermia Oncologic Working Group trial.Ifosfamide,carboplatin,and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma[J].Oncology(Basel),2003.312-321.
  • 7Kraybill WG,Olenki T,Evans SS. A phase Ⅰ study of fever-range whole body hyperthermia (FR-WBH) in patients withadvanced solid tumouts:correlation with mouse models[J].Int J Hyperthermis,2002.253-266.
  • 8Adachi S,Kokura S,Okayama T. Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines[J].International Journal of Hyperthermia,2009.210-219.
  • 9Jain RK. Normalization of tumor vasculature:an emerging concept in antiangiogenic therapy[J].Science,2005.58-62.doi:10.1126/science.1104819.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部